Literature DB >> 17977997

Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies.

Bruce Allan1, Dianne J Marais, Margaret Hoffman, Samuel Shapiro, Anna-Lise Williamson.   

Abstract

The prevalence of cervical human papillomavirus (HPV) in South African women (n = 1,073) increased from 20.4% (173/848) in women with normal cytology to 41.7% (48/115) in women with atypical squamous cells of undetermined significance, 70.2% (40/57) in women with low-grade squamous intraepithelial lesions, and 83% (44/53) in women with high-grade squamous intraepithelial lesions (HSILs). HPV types 16 and 35 were the dominant types in women with HSILs but not in women in the other categories.

Entities:  

Mesh：

Year:  2007        PMID： 17977997      PMCID： PMC2238131          DOI： 10.1128/JCM.01981-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Chapter 1: HPV in the etiology of human cancer.

Authors:  Nubia Muñoz; Xavier Castellsagué; Amy Berrington de González; Lutz Gissmann
Journal:  Vaccine       Date:  2006-06-23       Impact factor: 3.641

2.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.

Authors:  G M Clifford; S Gallus; R Herrero; N Muñoz; P J F Snijders; S Vaccarella; P T H Anh; C Ferreccio; N T Hieu; E Matos; M Molano; R Rajkumar; G Ronco; S de Sanjosé; H R Shin; S Sukvirach; J O Thomas; S Tunsakul; C J L M Meijer; S Franceschi
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

Review 3.  Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.

Authors:  Gary Clifford; Silvia Franceschi; Mireia Diaz; Nubia Muñoz; Luisa Lina Villa
Journal:  Vaccine       Date:  2006-06-02       Impact factor: 3.641

Review 4.  Chapter 11: HPV vaccines: commercial research & development.

Authors:  Stephen Inglis; Alan Shaw; Scott Koenig
Journal:  Vaccine       Date:  2006-06-23       Impact factor: 3.641

5.  Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.

Authors:  A R Giuliano; M Papenfuss; M Abrahamsen; C Denman; J G de Zapien; J L Henze; L Ortega; E M Brown de Galaz; J Stephan; J Feng; S Baldwin; F Garcia; K Hatch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-11       Impact factor: 4.254

6.  Human papillomavirus genotypes in rural Mozambique.

Authors:  X Castellsagué; C Menéndez; M P Loscertales; J R Kornegay; F dos Santos; F X Gómez-Olivé; B Lloveras; N Abarca; N Vaz; A Barreto; F X Bosch; P Alonso
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

Review 7.  Human papillomavirus (HPV) infection in Southern Africa: prevalence, immunity, and vaccine prospects.

Authors:  Anna-Lise Williamson; Dianne Marais; Jo-Ann Passmore; Ed Rybicki
Journal:  IUBMB Life       Date:  2002 Apr-May       Impact factor: 3.885

8.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.

Authors:  Long Fu Xi; Papa Touré; Cathy W Critchlow; Stephen E Hawes; Birama Dembele; Papa Salif Sow; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2003-03-01       Impact factor: 7.396

10.  Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis.

Authors:  G M Clifford; J S Smith; T Aguado; S Franceschi
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640
View more
  19 in total

1.  Human papillomavirus genotype distribution among human immunodeficiency virus (HIV)-infected and non-HIV-infected women in Soweto, South Africa.

Authors:  David Adler; Guy de Bruyn; Fatima Laher; Glenda Gray; Bruce R Allan; Anna-Lise Williamson
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

Review 2.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

Authors:  Hugo De Vuyst; Laia Alemany; Charles Lacey; Carla J Chibwesha; Vikrant Sahasrabuddhe; Cecily Banura; Lynette Denny; Groesbeck P Parham
Journal:  Vaccine       Date:  2013-12-29       Impact factor: 3.641

3.  High Rate of Multiple Concurrent Human Papillomavirus Infections among HIV-Uninfected South African Adolescents.

Authors:  David Adler; Fatima Laher; Melissa Wallace; Katherine Grzesik; Heather Jaspan; Linda-Gail Bekker; Glenda Gray; Ziyaad Valley-Omar; Bruce Allan; Anna-Lise Williamson
Journal:  J Immunol Tech Infect Dis       Date:  2013

4.  The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.

Authors:  Samira Zoa Assoumou; Anicet Luc M Boumba; Angelique Ndjoyi-Mbiguino; Abdelkrim Khattabi; Moulay Mustapha Ennaji
Journal:  Med Oncol       Date:  2014-12-12       Impact factor: 3.064

5.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

6.  Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women.

Authors:  Dianne J Marais; Debbie Constant; Bruce Allan; Henri Carrara; Margaret Hoffman; Samuel Shapiro; Chelsea Morroni; Anna-Lise Williamson
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

7.  Human papillomavirus seropositivity and subsequent risk of HIV acquisition in rural South African women.

Authors:  Frank Tanser; Kyle G Jones; Johannes Viljoen; John Imrie; Erofili Grapsa; Marie-Louise Newell
Journal:  Sex Transm Dis       Date:  2013-07       Impact factor: 2.830

8.  Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa.

Authors:  Alicia C McDonald; Lynette Denny; Chunhui Wang; Wei-Yann Tsai; Thomas C Wright; Louise Kuhn
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

9.  Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits.

Authors:  Tracy L Meiring; Anna T Salimo; Beatrix Coetzee; Hans J Maree; Jennifer Moodley; Inga I Hitzeroth; Michael-John Freeborough; Ed P Rybicki; Anna-Lise Williamson
Journal:  Virol J       Date:  2012-08-16       Impact factor: 4.099

10.  Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia.

Authors:  Melkamu Getinet; Baye Gelaw; Abinet Sisay; Eiman A Mahmoud; Abate Assefa
Journal:  BMC Clin Pathol       Date:  2015-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.